Original Research ARTICLE
Establishing Porcine Monocyte-Derived Macrophage and Dendritic Cell Systems for Studying the Interaction with PRRSV-1
- 1Virology Department, Animal and Plant Health Agency, Surrey, UK
- 2Faculty of Health and Medical Sciences, University of Surrey, Surrey, UK
Monocyte-derived macrophages (MoMØ) and monocyte-derived dendritic cells (MoDC) are two model systems well established in human and rodent systems that can be used to study the interaction of pathogens with host cells. Porcine reproductive and respiratory syndrome virus (PRRSV) is known to infect myeloid cells, such as macrophages (MØ) and dendritic cells (DC). Therefore, this study aimed to establish systems for the differentiation and characterization of MoMØ and MoDC for subsequent infection with PRRSV-1. M-CSF differentiated MoMØ were stimulated with activators for classical (M1) or alternative (M2) activation. GM-CSF and IL-4 generated MoDC were activated with the well established maturation cocktail containing PAMPs and cytokines. In addition, MoMØ and MoDC were treated with dexamethasone and IL-10, which are known immuno-suppressive reagents. Cells were characterized by morphology, phenotype, and function and porcine MØ subsets highlighted some divergence from described human counterparts, while MoDC, appeared more similar to mouse and human DCs. The infection with PRRSV-1 strain Lena demonstrated different replication kinetics between MoMØ and MoDC and within subsets of each cell type. While MoMØ susceptibility was significantly increased by dexamethasone and IL-10 with an accompanying increase in CD163/CD169 expression, MoDC supported only a minimal replication of PRRSV These findings underline the high variability in the susceptibility of porcine myeloid cells toward PRRSV-1 infection.
Myeloid cells differentiate into various types of mononuclear phagocytic cells among them MØs and DCs. In order to facilitate a range of complex functions, both MØs and DCs demonstrate phenotypic and functional heterogeneity according to their activation or maturation state. It is the pathogen/disease situation and signals from the surrounding microenvironment, which determine the state of MØs and DCs, resulting in several subsets that in turn determine the disease outcome. The study and characterization of myeloid cells is, therefore, an essential starting point in understanding virus kinetics and interactions with host cells. Current understanding of myeloid cells is based on studies using human cells or mouse models, whereas other species are not characterized to the same extent. Since important differences have been highlighted between mouse and human myeloid cell systems, the understanding of myeloid cells is equally important to aid the understanding of veterinary diseases.
Activated MØs contribute to specific functional roles within the immune response (Gordon and Taylor, 2005). Two MØ subsets are recognized, referred to as M1 and M2, which result from classical or alternative activation, respectively (Nathan, 1991; Gordon, 2003). Classical (M1) activation of MØ requires two signals, namely IFN-γ and TLR ligation (Mosser, 2003), and can be generated in vitro using IFN-γ and LPS (Nathan, 1991; Held et al., 1999). M1 macrophages are able to kill intracellular pathogens (Mosser and Edwards, 2008), and pro-inflammatory cytokines including IL-1β, TNF, IL-6, IL-12, and IL-23 (Verreck et al., 2004; Mantovani et al., 2005). In response to LPS, mouse M1 produce inducible nitric oxide synthase (iNOS; MacMicking et al., 1997), whereas human macrophages do not (Thoma-Uszynski et al., 2001).
Alternative (M2) activation of macrophages occurs via IL-4 or IL-13 (Stein et al., 1992). Resulting macrophages show increased mannose receptor expression (CD206) and are distinct from M1 MØs by their limited killing ability (Modolell et al., 1995). M2 MØs are associated with wound repair (Gordon, 2003), producing components for extracellular matrix synthesis (Gratchev et al., 2001). Other alternative activation of macrophages occurs with IL-10, glucocorticoids, and vitamin D3. Although the ‘M2’ nomenclature is often also applied to these cells, they show little similarity with IL-4/IL-13 M2 activated MØs (Mantovani et al., 2004).
Myeloid DCs also exist as different subsets according to their activation. In tissues, DCs reside in an immature state, unable to stimulate T-cells. iDCs are well equipped for antigen uptake via phagocytosis (Svensson et al., 1997), macropinocytosis (Sallusto et al., 1995), or receptor-mediated endocytosis (Sallusto and Lanzavecchia, 1994; Jiang et al., 1995), but maturation of DCs and accessory signals (e.g., CD80/86) required for T-cell activation are necessary for primary immune responses. DC maturation occurs by way of ‘danger signals.’ This can be mimicked in vitro using a cocktail of factors including TLR ligands, such as LPS, inflammatory cytokines (TNF-α, IL1-β, and IL-6), and molecules released following tissue damage such as PGE2 (Scandella et al., 2002; Jeras et al., 2005).
Significant differences have also been identified between mouse and human DC subtypes (Vereyken et al., 2011). Comparative analysis suggests that the pig’s immune system is more closely resembled to that of the human (Schook et al., 2005), but pigs are important in their own right as the most important meat producing mammalian livestock species worldwide, and host to several pathogens, including zoonoses.
An important disease of swine is PRRS, caused by the virus PRRSV, which infects cells of myeloid lineage (Snijder and Meulenberg, 1998), the proposed targets being alveolar macrophages and other tissue macrophages, but less so monocytes and DCs (Haynes et al., 1997; Van Gorp et al., 2008). PRRSV, belonging to genus Arterivirus (Snijder and Meulenberg, 1998; Meulenberg, 2000) is responsible for respiratory disease in pigs and reproductive failure in sows, affecting the swine industry worldwide (Hopper et al., 1992; Done and Paton, 1995; Rossow, 1998). Having emerged in North America during the late 1980s, PRRSV was identified in Europe shortly afterward (Lindhaus and Lindhaus, 1991). PRRSV-1 (European) and PRRSV-2 (North American), cause a similar syndrome, despite sharing only 55–70% nucleotide identity (Forsberg et al., 2002), which has led to the suggestion to consider these as separate virus species. Sequence analysis of PRRSV-1 strains defined at least three distinct subtypes, namely subtype 1 (pan-European) and Eastern European subtypes 2 and 3 (Stadejek et al., 2008, 2013). PRRSV isolates show significant differences in virulence and highly pathogenic (HP) PRRSV strains first arose in PRRSV-2 strains (Tong et al., 2007), but were since also identified in PRRSV-1 subtype 3 such as strains Lena and SU1-Bel (Karniychuk et al., 2010; Morgan et al., 2013; Weesendorp et al., 2013).
Porcine reproductive and respiratory syndrome virus has a restricted cell tropism and infection of porcine alveolar macrophages is well described in vitro and in vivo (Haynes et al., 1997; Gomez-Laguna et al., 2013), although variability in macrophage susceptibility was observed in vitro (Duan et al., 1997a; Vincent et al., 2005) and peritoneal macrophages as well as macrophage precursor cells, i.e., bone marrow cells and peripheral blood monocytes, are reportedly refractory to PRRSV infection (Duan et al., 1997a,b; Teifke et al., 2001). PRRSV has been detected in or isolated from macrophages of various tissues, including the spleen, liver, Peyer’s patches, thymus, and placenta (Larochelle et al., 1996; Sur et al., 1996; Duan et al., 1997a,b; Lawson et al., 1997; Karniychuk and Nauwynck, 2009). In contrast, PRRSV infection of DCs is poorly understood and there are possibly significant differences between PRRSV-1 and -2. PRRSV-2 infection of MoDC is frequently described (Wang et al., 2007; Flores-Mendoza et al., 2008; Park et al., 2008) and infection of bone marrow derived DCs (BMDC) was apparent (Chang et al., 2008), whereas reports of PRRSV-1 infection of DCs are very few (Silva-Campa et al., 2010).
It was hypothesized that PRRSV is able to elicit immunosuppression (Drew, 2000; Diaz et al., 2005), although no direct evidence of such by PRRSV-1 exists to date (Mateu and Diaz, 2008). More detailed reviews of host interactions with PRRSV-1 conclude that most PRRSV-1 strains initiate weak innate immune responses, resulting in prolonged viremia and persistent infection, whereas strains that induce a significant inflammation are cleared more effectively (Morgan et al., 2013; Weesendorp et al., 2013; Salguero et al., 2015). However, previous in vitro studies of PRRSV-2 imply that it impairs DC function directly by modulation of important molecules, including the down-regulation of MHC-I and MHC-II (Loving et al., 2007; Wang et al., 2007; Park et al., 2008). This suggested PRRSV-2 infected DCs were less efficient at presenting antigens to T cells.
Although well described in humans and mice, differentiation of monocytes to MØs in vitro is not well established for pigs, although studies using L929-conditioned media as a source of M-CSF indicate its feasibility (Mayer, 1983; Genovesi et al., 1990) and human M-CSF has been used to generate porcine macrophages from bone marrow (Kapetanovic et al., 2012), which expressed macrophage markers (CD14, CD16, and CD172a), and were phagocytic. Indicative of classical activation, these responded to LPS treatment by TNF-α production, but like human M1 MØs, lack NO production (Kapetanovic et al., 2012). MoMØ showed an altered phenotype compared to monocytes, including the expression of porcine macrophage marker CD203a (McCullough et al., 1997, 1999). Few studies of porcine M1 and M2 phenotypes generated from MoMØ have yet been carried out, and it is important to further characterize porcine macrophages (Ezquerra et al., 2009).
In vitro generation of DCs from monocytes (MoDC) using growth factor GM-CSF and IL-4 is established in various species, including cats (Mizukoshi et al., 2009), horses (Moyo et al., 2013), and cattle (Howard et al., 1999). Porcine MoDC generation from was reported before, using slightly different conditions (Carrasco et al., 2001; Paillot et al., 2001).
Porcine reproductive and respiratory syndrome virus 1 entry is thought to occur via receptor-mediated endocytosis. CD163 and sialoadhesin (CD169) were considered essential for PRRSV-1 entry in macrophages (Van Breedam et al., 2010a). CD169, a type 1 transmembrane protein restricted to macrophages (Munday et al., 1999), directly binds to sialic acids present on M/GP5 glycoprotein complexes in the PRRSV envelope. Transfection of CD169 into non-permissive cell lines enabled PRRSV attachment and internalization via endocytosis (Vanderheijden et al., 2003; Van Breedam et al., 2010b), but not productive infection, suggesting that an additional factor was required. CD163, also a type 1 transmembrane glycoprotein expressed mainly on certain monocytes and macrophages (Hogger et al., 1998), is implicated in later stages of PRRSV entry (Van Breedam et al., 2010a), considered essential for genome release, potentially requiring interaction with the minor envelope glycoproteins GP2a and GP4 (Das et al., 2010).
As investigations of MoMØ and MoDC subsets in pigs remain elusive, our aim was to describe both cell types in vitro, distinguishing different sub-populations by phenotypical and functional analysis, and using them to assess how these cells react to PRRSV-1 infection with a highly pathogenic strain (Lena).
Materials and Methods
Porcine Myeloid Cell Isolation and Culture
All porcine primary cells were collected from Large White cross Landrace pigs under the age of 2 years. All work was carried out under license from the UK Home Office (PPL 70/7057) under the Animal Act 1986 and approved by the ethics committee at APHA. Briefly, approximately 200 ml of venous blood was collected into sterile duran bottles containing 25 IU of heparin sodium (LEO, Ballerup, Denmark) to prevent blood coagulation. Each 30 ml was layered onto 20 ml Biocoll separating solution, 1.077 g/ml density (Biochrom, Berlin, Germany) and centrifuged at 1455 × g for 30 min at room temperature. The PBMC interface was removed and washed with 4°C Dulbecco’s PBS (PBS; Invitrogen, Paisley, UK). PBMC were counted and resuspended in 10 μl anti-human CD14 MicroBeads (Miltenyi Biotec, Gergisch Gladbach, Germany) per 107 cells and incubated at room temperature for 12 min. After washing with PBS + 2% fetal bovine serum (FBS), cells were resuspended in 500 μl PBS + 2% FBS + 5 mM EDTA (Sigma, Poole, UK; MACS buffer) per 108 cells and applied to a MACS LS column placed on a magnetic quadro MACS unit (Miltenyi Biotec). Flow through was collected as the CD14- fraction and after washing the column with MACS buffer, the CD14+ fraction was collected in RPMI-1640 media +10% FBS, 100 IU/ml of penicillin, 100 μg/ml of streptomycin, and 50 μg/ml of gentamicin (all Invitrogen; complete tissue culture [TC] medium) and cultured on ultra-low bind (ULB) plates at 37°C with 5% CO2.
For differentiation of monocytes to MoMØ, freshly isolated monocytes were cultured at a cell density of 1 × 106/ml in complete TC medium supplemented with 50 ng/ml of recombinant human M-CSF (Miltenyi Biotec) for 4 days. For differentiation of monocytes to MoDC, freshly isolated monocytes were cultured at a cell density of 2 × 106/ml (1 ml/well) in complete TC medium supplemented with 10 ng/ml of recombinant porcine GM-CSF and 10 ng/ml of recombinant porcine IL-4 (R&D Systems, Abingdon, UK) for 4 days. Cell differentiation was monitored by assessment of cell morphology using light microscopy and phenotypic and functional characterization.
For MoMØ activation, culture medium was replaced after 4 days with fresh TC medium containing 10 ng/ml of LPS (from Salmonella Minnesota; Enzo Life Sciences, Exeter, UK) and 100 ng/ml of recombinant porcine IFN-γ (R&D Systems) for classical activation of MoMØ (M1 macrophages). For alternative activation (M2 macrophages), 10 ng/ml of recombinant porcine IL-4 was added. Alternatively MoMØ were also treated with 10 μg/ml of water soluble dexamethasone (Sigma) or 10 ng/ml of recombinant porcine IL-10 (R&D Systems) for 24 h.
Monocyte-derived dendritic cells were treated with a maturation cocktail for 24 h. This contained 100 ng/ml of LPS (Salmonella Minnesota), 100 ng/ml of porcine IFN-γ, 20 ng/ml of porcine TNF-α, 20 ng/ml of equine IL-6, 10 ng/ml of equine IL-1β, and 1 μg/ml of PGE2 (all R&D Systems).
Endocytosis was assessed using allophycocyanin (APC)-labeled ovalbumin (OVA; Invitrogen). Cells were resuspended in cold TC medium and added to 96-well round bottom plates at 1 × 105/well. APC-OVA was added to cells at 20 μg/ml and incubated for 1 h at either 4°C (control) or 37°C. Cells without beads were used as a further negative control. Cells were washed three times with cold PBS, and stained for viability using LIVE/DEAD violet fixable dye (Invitrogen) before flow cytometric analysis.
Phagocytosis was assessed using fluorescein isothiocyanate (FITC)-labeled sulfate FluoSpheres®microsphere particles (4 μm diameter) or FITC-labeled carboxylate-modified microspheres (1 μm diameter; both Invitrogen). Cells were split between two wells of a 24-well ULB plate to allow for a control well without particles, and supplemented with 500 μl of fresh RPMI resulting in a cell density of 5 × 105/ml. Microspheres were added at 2 × 105 beads/ml and incubated for 3 h at either 4°C (control) or 37°C. Cells were then harvested and washed three times in cold PBS and subsequently stained for viability using LIVE/DEAD violet fixable dye before flow cytometric analysis.
All flow cytometry was carried out using a MACSQuant Analyzer flow cytometer (Miltenyi Biotec). Antibodies were added to cell pellets following harvesting from plates and centrifugation. For elimination of dead cells, cells were resuspended in LIVE/DEAD violet fixable dye and incubated at RT for 20 min protected from light.
For surface molecule staining, cells were added to round bottom 96-well plates (∼5 × 105/well) and stained with relevant antibodies (Table 1) at 4°C for 30 min before washing in PBS + 1% FBS + 0.09% sodium azide (FACS buffer). Single color stained cells and unstained cells were used to calculate compensation for fluorescence spill-over. Individual samples were also stained with isotype negative controls of corresponding concentration to the relative antibody where described. Prior to analysis, cells were resuspended in CellFix (BD Biosciences, Oxford, UK).
For analysis of PRRSV infection cells were added to round bottom 96-well plates (∼5 × 105/well) before being fixed and permeabilized using the CytoFix/CytoPerm kit according to the manufacturer’s protocol (BD Biosciences). PRRSV specific monoclonal antibody SDOW-17 (Rural Technologies Inc, Brookings, SD, USA) was diluted 1/20 in PermWash and 5 μl was added to each well and incubated for 30 min at 4°C. Anti-mouse IgG1 isotype control was used to assess for non-specific binding. Cells were washed twice, and stained with anti-mouse IgG1-APC conjugated secondary reagent (BD Biosciences).
PRRSV-1 Virus Infection and Detection
Porcine reproductive and respiratory syndrome virus 1 strain Lena is a particularly pathogenic subtype 3 strain isolated from Belarus (Karniychuk et al., 2010) that was supplied by Prof. Hans Nauwynck (Ghent University, Ghent, Belgium). Virus was propagated and titrated on porcine alveolar macrophages prior to this study, as previously described (Morgan et al., 2013). Cells were infected with PRRSV-1 strain Lena at a multiplicity of infection (m.o.i.) of 0.1. Time-zero samples were obtained following 2 h of incubation with virus at 4°C to achieve attachment but no internalization of virus. At different time-points post infection (p.i.), cell supernatant was removed for analysis of infection by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and cells were harvested and centrifuged to obtain cell pellets. Cell pellets or supernatants were stored at -70°C prior to RNA extraction. A QiaAmp Viral RNA Mini Kit (Qiagen, Manchester, UK) was used to extract RNA from 140 μl of cell supernatant, or cells resuspended in 140 μl AVL buffer. RNA was eluted into 60 μl of elution buffer and stored at -20°C prior to RT-PCR analysis. For PRRSV detection by qRT-PCR, 2 μl of RNA was added to 23 μl of a PCR mastermix containing PRRSV-1 specific forward/reverse primers and probe (Frossard et al., 2012) and the Quantitect RT-PCR Kit (Qiagen). For RNA extracted from cells, a eukaryotic 18S rRNA RT-PCR was used as endogenous control to allow normalization (Applied Biosystems, Paisley, UK). qRT-PCRs were carried out using a Mx3000P real time PCR system (Agilent, La Jolla, CA, USA) as described before (Morgan et al., 2013).
To quantify PRRSV in cell supernatants, Ct values of PRRSV at 2 h p.i. (i.e., time-zero negative control) were subtracted from Ct values of PRRSV detected at each time-point p.i., providing a ΔCt, which was transformed into a fold increase as a measure of replication. Alternatively, where replication was measured in cells, relative quantitation was used to analyze changes between the time-zero negative control and time p.i., using normalization against 18S rRNA levels using the ΔΔCt method (Livak and Schmittgen, 2001).
Statistical tests were performed using GraphPad Prism Software, version 6.01. All experiments were performed independently at least three times using cells isolated from three different pigs unless stated otherwise. Statistical tests such as One-way or Two-way analysis of variance (ANOVA) and student t-tests were performed as detailed in the results.
Differentiation and Characterization of Monocyte-Derived Macrophages (MoMØ)
After 4 days with M-CSF, monocytes developed macrophage morphology (enlarged, adherent, round). Upon treatment for 24 h with LPS/IFN-γ (M1) these cells displayed increased formation of cell clusters, whereas IL-4 treated MoMØ (M2) had noticeably more elongated projections (Supplementary Figure S1). Surface expression of myeloid lineage and activation markers revealed that the percentage of M2 MoMØ expressing CD203a, was significantly higher than for unstimulated MoMØ (p < 0.001) and M1 MoMØ (p < 0.001), whereas expression of CD14, CD206, CD163, and CD169 remained unchanged (Figure 1A). However, MHC-II was detected on a significantly higher percentage of M1 MoMØ than on unstimulated MoMØ (p < 0.0001) and M2 MoMØ (p < 0.001) and the percentage of cells expressing CD80/86 was also significantly higher in M1 MoMØ, compared to unstimulated MoMØ (p < 0.001) and M2 MoMØ (p < 0.05). Further, more M1 MoMØ also expressed IL-2 receptor alpha CD25 (p < 0.05), whereas significantly less M1 MoMØ expressed CD209 (DC-SIGN) than unstimulated MoMØ (p < 0.001), and M2 MoMØ (p < 0.001; Figure 1B). CD83 expression was unchanged between unstimulated and M1 or M2 MoMØ. Endocytic and phagocytic activity of porcine monocyte-derived macrophages (PoMoMØ) following treatment with M1 or M2 activators was also assessed, but no significant differences were observed (Supplementary Figures S2 and S3).
FIGURE 1. Phenotypical analysis of porcine M1 and M2 MoMØs. Freshly isolated peripheral porcine monocytes were treated with M-CSF for 4 days to obtain MoMØs. MoMØs were treated with IFN-γ and LPS to generate M1 macrophages (blue) or with IL-4 to generate M2 macrophages (orange), or MoMØs were left unstimulated (unfilled bars). After a further 24 h MoMØ were harvested and stained with various antibodies to assess their surface expression of pathogen recognition receptor/lineage markers (A) or antigen presentation/co-stimulatory molecules (B) for flow cytometry analysis. Data represent mean percentage of cells expressing markers +SD. One-way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison test ∗∗∗p < 0.0001, ∗∗p < 0.001, ∗p < 0.05.
Dexamethasone (dexa) and IL-10 were also applied to activate MoMØ. Light microscopy showed that dexa treated MoMØ appeared more rounded, with some enlarged cells compared to unstimulated MoMØ, while IL-10 treated MoMØ noticeably clustered together more frequently (Supplementary Figure S1). Thus both dexa and IL-10 treated MoMØ appeared unlike M1 and M2 MoMØ supporting the notion that they are not M2 macrophages (Gordon, 2003; Mantovani et al., 2005). Dexa and IL-10 treatment of MoMØ also resulted in two distinct MoMØ phenotypes, both showing differences to M1 and M2 MoMØ phenotypes. Dexa treated MoMØ showed significantly higher percentages of cells expressing CD163 (p < 0.0001), as did IL-10 treated MoMØ (p < 0.05), but the percentage of cells expressing CD163, was significantly higher in dexa MoMØ than IL-10 MoMØ (p < 0.005). IL-10 treated MoMØ showed significantly higher percentages of cells positive for CD203a than unstimulated (p < 0.001) and dexa treated MoMØ (p < 0.05). No differences were observed in the percentage expression of CD206 or CD169 in dexa or IL-10 treated MoMØ (Figure 2A). No differences were observed in the MHCII expression, but a lower proportion of IL-10 treated MoMØ expressed CD80/86 (p < 0.05). Both dexa and IL-10 treatment of MoMØ resulted in a decreased percentage of cells expressing CD83 (both p < 0.001), whereas no differences were observed in the percentage of cells positive for CD25 or CD209 (Figure 2B). Flow cytometric analysis determined that IL-10 treated MoMØ displayed significantly increased endocytosis (75.8%) compared with both dexa MoMØ (56.5%) and M2 MoMØ (57.2%; p < 0.05; Supplementary Figure S4). In two of five pigs, phagocytosing microsphere particles were also increased in dexa MoMØ (Supplementary Figure S5).
FIGURE 2. Phenotypic analysis of dexa and IL-10 treated MoMØs. Freshly isolated peripheral porcine monocytes were treated with M-CSF for 4 days to obtain MoMØs. MoMØs were treated with dexa (blue) or IL-10 (orange) or left unstimulated (unfilled bars). After a further 24 h MoMØs were harvested and surface stained for pathogen recognition receptors/lineage markers (A) or antigen presentation/co-stimulatory molecules (B) for flow cytometric analysis. Data represent mean percentage of cells expressing markers +SD. One-way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison test ∗∗∗p < 0.0001, ∗∗p < 0.001, ∗p < 0.05.
PRRSV-1 Lena Infection of MoMØ Subsets
Porcine reproductive and respiratory syndrome virus 1 replication within MoMØ subsets was assessed by both qRT-PCR and flow cytometry at 16 h p.i. Only dexa treatment showed a significant increase in PRRSV-1 replication measurable by both methods (Figure 3, Supplementary Figure S6). In contrast, neither classical (M1) nor alternative (M2) macrophage activation resulted in changes at this time-point. After 16 h p.i., PRRSV-1 replication in dexa treated macrophages did not seem to increase further, and other MoMØ reached similar replication levels by around 72 h p.i. Interestingly, M1 MoMØ showed negative ΔΔCt values at 24 and 48 h (Figure 3), indicating a major obstacle for PRRSV-1 replication. However, PRRSV-RNA was detected in M1 cells after 72 h p.i. (Figure 3). In line with qRT-PCR results, only dexa MoMØ showed significant levels of PRRSV N protein expression (Supplementary Figure S6). At 16 h p.i., PRRSV-RNA levels in culture supernatants were low and no differences were observed between MoMØ subsets (Figure 4). At 20 h p.i., clear differences started to emerge, i.e., dexa MoMØ produced the highest amount of PRRSV-1, while M1 MoMØ did not show any significant PRRSV-1 production until around 48 h p.i.
FIGURE 3. PRRSV replication in MoMØs following different activation stimuli. Monocytes were treated with M-CSF for 4 days to generate MoMØs, and either left unstimulated (red) or activated with LPS and IFN-γ (M1; pink), IL-4 (M2; green), dexa (orange) or IL-10 (blue) for 24 h before infection with PRRSV Lena using an m.o.i of 0.1. RNA was extracted from cells at either 16, 24, 48, or 72 h p.i, and a TaqMan qPCR was used to quantify PRRSV RNA. ΔΔCt represents difference between Ct at 2 h p.i (time zero) and Ct at each time point p.i after normalization against 18S RNA. Bars represent mean ΔΔCt ± SD.
FIGURE 4. PRRSV replication in MoMØ subset supernatant over time. Monocytes were treated as in Figure 3. Viral RNA was extracted from cell supernatant at 16, 20, 24, 36, or 48 h p.i, and a TaqMan qPCR was used to obtain Ct values. ΔCt represents difference between Ct at 2 h p.i (time zero) and Ct at each time point p.i shown at 16, 20, 24, 36, 48, or 72 h time-points in unstimulated (red), M1 (pink) M2 (green), dexa (blue) or IL-10 (orange) treated MoMØs. Lines represent mean ΔCt ±SD in three independent experiments, each biological repeat tested in duplicate (n = 2 at 72 h p.i). ∗∗p < 0.001, ∗p < 0.05.
Characterization of Porcine MoDC
After 4 days with GM-CSF and IL-4, monocytes developed typical DC morphology, with cell clusters displaying surface protrusions. Twenty-four hours culture with the standard maturation cocktail resulted in no significant morphological changes, although maturation cocktail treated MoDC were less adherent than untreated MoDC (Supplementary Figure S7). DC maturation cocktail did induce some significant changes to MoDC phenotype, however. A significant increase was observed in expression of both CD80/86 (p < 0.001) and CD83 (p < 0.001), while MHC-II expression remained high (Figure 5). The number of maturation cocktail treated MoDC expressing CD14 was significantly lower than on immature (i) MoDC (p < 0.001); CD206 and CD209 (DC-SIGN) remained low, as did CD203a. The percentage of cells expressing CD163 and CD169 was negligible in both untreated and treated MoDC (Figure 5B).
FIGURE 5. The effect of maturation cocktail on porcine MoDC. Four-day-old MoDC were treated with a maturation cocktail for 24 h before flow cytometric analysis of surface molecules involved in DC maturation or antigen presentation (A) and other co-stimulatory molecules and lineage markers (B) in untreated iMoDC (white bars) and cytokine maturation cocktail treated (blue bars) MoDCs. Bars show mean percentage of cells expressing each marker +SD. Two-way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison test, ∗∗p < 0.001.
Following 24 h treatment with dexa, MoDC appeared to have fewer and less dense clusters than untreated MoDC, but still maintained cellular elongation. In contrast, IL-10 treated MoDC appeared similar to untreated MoDC, with fewer cellular elongations (Supplementary Figure S7). Dexa treatment also resulted in a distinct MoDC phenotype, while IL-10 treatment rather maintained the iMoDC phenotype (Figure 6). Specifically the expression of CD1, CD14, CD206, and CD209 was up-regulated by dexa. Dexa MoDCs expressed almost twice as much CD14 and significantly more CD1 than maturation cocktail treated MoDC CD25 expression, however, was decreased following dexa treatment (p < 0.0001). In contrast to MoMØ, neither dexa nor IL-10 treatment affected expression of CD163 and CD169 on MoDC; the percentage of cells expressing these molecules remained below 10%.
FIGURE 6. The effects of dexamethasone and IL-10 treatment on the phenotype of porcine MoDCs. Four-day-old MoDCs were treated with either dexamethasone or IL-10 for 24 h before surface staining with various anti-porcine or anti-human mono/poly-clonal antibodies for flow cytometric analysis of surface molecules involved in antigen presentation and maturation (A) or against other co-stimulatory molecules and myeloid lineage markers (B) in untreated MoDCs (unfilled bars), dexa treated MoDCs (blue bars), or IL-10 treated MoDCs (orange bars). Bars show mean percentage of cells expressing each marker +SD (A,B). One-way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison test ∗∗∗p < 0.0001, ∗∗p < 0.001, ∗p < 0.05.
Endocytosis was much lower in MoDC than observed in MoMØ. Percentages of cells associated with APC-OVA, indicative of endocytosis, were unchanged between iMoDC and mMoDC. In contrast, both dexa and IL-10 treatment of MoDC, appeared to increase endocytosis. However, replicate experiments were variable, and as a result only dexa treated MoDC showed a statistically significant increase in endocytic activity (p < 0.05; Figure 7). Levels of phagocytosis in MoDC subsets were also below those observed in MoMØ. Whilst maturation cocktail treatment did not induce changes, IL-10 treated MoDC showed statistically higher percentages of cells associated with FITC-labeled particles compared to iMoDC and mMoDC (p < 0.05; Figure 8).
FIGURE 7. The effect of dexa treatment on MoDC levels of endocytosis. The ability of immature/iMoDC (untreated), mature/mMoDC (maturation cocktail treated) to endocytose APC∗-labeled OVA was assessed. Cells were incubated with OVA at 4°C as a negative control (blue dots), or at 37°C (red dots), for 1 h before flow cytometric analysis of APC∗ fluorescence. Each dot represents the percentage of cells fluorescing APC∗, indicating endocytic OVA uptake, in individual experiments. Lines represent mean percentages of cells associated with OVA-APC∗ ±SEM. One-way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison test, ∗p < 0.05.
FIGURE 8. The effect of IL-10 treatment on MoDC levels of phagocytosis. The ability of untreated immature/iMoDC, maturation cocktail treated mature/mMoDC, dexa treated MoDC and IL-10 treated MoDC to phagocytose FITC-labeled microsphere particles was assessed. Cells were incubated with particles at 4°C as a negative control (blue dots), or at 37°C (red dots), for 3 h before flow cytometric analysis of FITC fluorescence. Each dot represents the percentage of cells fluorescing FITC, indicating phagocytic uptake, in individual experiments. Lines represent the mean percentage of cells associated with FITC microsphere particles ±SEM. ∗p < 0.05
PRRSV Lena Infection of MoDC Subsets
At 16 h p.i., viral replication was generally low in MoDC, with dexa MoDC being particularly inefficient and mMoDC displaying a slightly higher replication level. At 24 h p.i., viral replication appeared to increase but without showing significant differences between subsets (Figure 9). After 48 h viral replication in some MoDC subsets showed slight increases particularly dexa MoDC and IL-10 MoDC, but these differences were not significant. In line with qRT-PCR results, no PRRSV protein expression could be detected by intracellular flow cytometry staining at 20 h p.i. (not shown). At 16 h p.i., PRRSV was undetectable in MoDC supernatants, indicating a longer time for a single round of virus replication in all MoDC (Figure 10). Only after 36 h p.i. clear signs of viral production were seen in the supernatant of IL-10 and dexa treated MoDC, albeit at very low levels. This trend remained until the endpoint at 72 h p.i., with some evidence of virus production in iMoDC, whereas mMoDC seemed to be particularly refractory to PRRSV replication (Figure 10). Due to variability between biological repeats, no statistically significant differences were observed between MoDC subsets.
FIGURE 9. qPCR detection of PRRSV replication in MoDC subsets at 16, 24, 48, and 72 h post infection. Immature/iMoDC (black), maturation cocktail treated mature/mMoDC (dark blue), dexa treated MoDC (light blue), and IL-10 treated MoDC (orange), were infected with PRRSV Lena using an m.o.i of 0.1. Viral RNA was extracted from cells at either 16, 24, 48, or 72 h p.i and a TaqMan qPCR with an 18S endogenous control was used to obtain Ct values. ΔΔCt represents difference between Ct at 2 h p.i (time zero) and Ct at each time point p.i, both normalized to 18S. Bars represent mean ΔΔCt ± SD.
FIGURE 10. PRRSV replication in MoDC supernatant between 16 and 72 h p.i. Immature/iMoDC (black), maturation cocktail treated mature mMoDC (dark blue), dexa treated MoDC (light blue) and IL-10 treated MoDC (orange) for 24 h before infection with PRRSV Lena using an m.o.i of 0.1. Viral RNA was extracted from cell supernatant at 16, 20, 24, 36, 48, or 72 h p.i, and TaqMan qPCR was used to obtain Ct values. ΔCt represents difference between Ct at 2 h p.i (time zero) and Ct at each time point p.i. Bars represent mean ΔCt ± SD.
This study aimed to characterize subsets of macrophages and DCs derived from porcine monocytes, and to determine whether these cells could be used to explore PRRSV-1 infection kinetics within porcine myeloid cell sub-populations.
Classical and Alternative Activation of Porcine MoMØ
Morphological and phenotypical analysis of poMoMØ treated with M1 (IFN-γ and LPS) or M2 cytokines (IL-4) resulted in two distinct populations, which are suggestive of different MØ activation pattern. Analysis of markers associated with classical and alternative activated macrophages in humans and mice suggested that despite some similarities, poMoMØ may not behave alike. Morphological changes were unexpected to be prominent, since human M1 and M2 macrophages lack any particular morphology (Porcheray et al., 2005; Vereyken et al., 2011). Our results align with this, as poMoMØ formed clusters suggestive of decreased adherence, consistent with Rey-Giraud et al. (2012) who describe increased detachment of human M1 macrophages. IL-4 treated poMoMØ showed smaller cell clusters joined by long projections which, as a typical IL-4 effect, are well documented and consistent with IL-4 treated mouse macrophages (Vereyken et al., 2011), possibly contributing to increased motility for migration to inflammation sites (Gordon, 2003).
Activation of poMoMØ led to significant changes in phenotype. Up-regulation of MHC and co-stimulatory molecules was consistent with the increased APC role of M1 activated macrophages (Gordon and Taylor, 2005). MHC-II up-regulation is a known effect of IFN-γ (Schroder et al., 2004), and CD86 expression alike was described in M1 macrophages (Mosser, 2003; Gordon and Taylor, 2005; Whyte et al., 2011). In addition CD25 was significantly increased on stimulated M1 poMoMØ, which as previously noted is a result of LPS in human monocytes (Scheibenbogen et al., 1992).
Important for migration (Geijtenbeek et al., 2000), DC-SIGN/CD209 expression is IL-4 dependent, associated with M2 macrophages (Martinez et al., 2006) and negatively regulated by IFNs (Relloso et al., 2002). Whilst we found that CD209 was significantly down-regulated in M1 MoMØ, we did not see IL-4 effects observed in other species. CD203a, significantly up-regulated on porcine M2 MoMØ, is a homolog to the human NPP1/CD203α, which regulates mineralization in articular cartilage and arterial tissues (Bollen et al., 2000; Goding et al., 2003), relating to the role of M2 macrophages in tissue repair.
Expression of both putative PRRSV-1 receptors CD163 and CD169 was unchanged in M1 or M2 MoMØ, which was particularly surprising in M2 MoMØ, given that others report this in human and mouse M2 macrophages, assumed to aid clearance of damaged cells (Gordon, 2003).
Dexa and IL-10 Treatment of MoMØ Results in Two Further MoMØ Phenotypes
Dexamethasone and IL-10 induced morphological changes unlike those observed with IFN-γ/LPS and IL-4. The rounded appearance was comparable to a proposed ‘condensed’ morphology of dexa treated human macrophages (Porcheray et al., 2005), and consistent with the proposed deactivation state (Gordon, 2003). IL-10 induced only slight morphological changes, in agreement with Rey-Giraud et al. (2012) who described unchanged morphology of IL-10 treated human macrophages.
Both dexa and IL-10 significantly decreased CD83 expression on MoMØ, whilst only IL-10 decreased CD80/86. Decrease of maturation markers is in line with the assumption that both dexa and IL-10 are immunosuppressive. Whilst still poorly understood, deactivation is considered a final stage, halting inflammation and tissue damage (Gordon, 2003). Up-regulation of CD203a was the only shared effect of IL-10 and IL-4, not shown before, and not a feature attributed to alternative activation. IL-10 significantly increased endocytosis, thereby suggesting that uptake was independent of CD206 expression. Both dexa and IL-10 treatment significantly up-regulated CD163 in MoMØ, in line with the over-expression of CD163 described on differentiated macrophages treated with dexa and IL-10 (Porcheray et al., 2005).
Whilst earlier studies (Stein et al., 1992; Rey-Giraud et al., 2012) demonstrate increased endocytic and phagocytic activity in M2 macrophages, an increase was also observed in classically activated mouse macrophages (Vereyken et al., 2011). While neither M1 nor M2 treatment of poMoMØ significantly altered antigen uptake, dexa enhanced phagocytosis and IL-10 enhanced endocytosis. IL-10 has been shown to enhance endocytic activity of porcine macrophages (Montoya et al., 2009) and MoDC (Longoni et al., 1998). While early reports suggest that dexa suppresses macrophage phagocytic activity (Becker and Grasso, 1985), our result is in line with more recent studies using human MoMØ where dexa enhanced phagocytosis (Zahuczky et al., 2011).
PRRSV-1 Susceptibility Varies across Different MoMØ Subsets
Previous studies have suggested that differences in disease susceptibility between pig breeds or individuals within pig breeds are correlated with differences in macrophage activation states (McCullough et al., 1993; Duan et al., 1997a; Ait-Ali et al., 2007).
Unchanged CD163 and CD169 expression following classical and alternative activation of MoMØ suggested that M1 or M2 MoMØ susceptibility to PRRSV-1 would be unaffected. We did not expect M1 macrophages to show such low replication levels. This failure, eventually overcome after 3 days, could be linked with the anti-viral effect of IFN-γ, which inhibits PRRSV-1 replication in vitro (Bautista and Molitor, 1999; Rowland et al., 2001).
Dexa significantly enhanced PRRSV-1 replication in MoMØ, associated with increased CD163 expression. Interestingly, dexa did not increase CD169, presumed the first receptor for PRRSV attachment (Calvert et al., 2007). Dexa’s ability to increase PRRSV replication with a significant effect on CD163 alone could suggest that CD169 was already sufficient before activation, or that it has no role in PRRSV, as suggested by Prather et al. (2013).
All MoMØ subsets appeared to increase their virus production into cell supernatant over time, however, the only significant differences observed between time-points were with IL-10 and dexa treatment up to 48 h p.i. Our data supports previous suggestions that one round of PRRSV replication in alveolar macrophages takes 9–16 h (Morilla, 2002), and suggests that further replication may have occurred subsequently.
Flow cytometric staining of PRRSV nucleocapsid protein was detected in dexa MoMØ only, which may be due to the low initial m.o.i. of 0.1. This was unexpected, since macrophages are considered the most favorable cell for PRRSV-1 tropism, where over time we expected a higher replication and spread through the culture. However, Thacker et al. (1998) detected only up to 38% of PRRSV-2 infected macrophages, using a m.o.i. of 1 (Thacker et al., 1998). It is thus reasonable to question if differentiated MØ are truly highly permissive for PRRSV.
Porcine MoDC Show a Mature Phenotype in Response to Cytokine Activation Cocktail
Porcine MoDC differentiation has been described before (Paillot et al., 2001; Chamorro et al., 2004) and the morphology observed here fully aligned with previous reports and studies in other species (Miranda de Carvalho et al., 2006; Moyo et al., 2013). Similarly, porcine MoDC (poMoDC) maturation is well established and molecules involved in antigen presentation were up-regulated as described in response to LPS alone (Carrasco et al., 2001; Flores-Mendoza et al., 2008; Facci et al., 2010), or a LPS/IFN-γ/TNF-α cocktail (Pilon et al., 2009).
CD1a and CD1b are considered hallmark human DC phenotypes (Cao et al., 2002; Dascher and Brenner, 2003). Here, in pigs, CD1 expression was unchanged following maturation, which is consistent with a previous report (Carrasco et al., 2001). It should be noted, however, that CD1 diverged evolutionarily and appears in various isoforms differing between species. While the pig CD1 locus is described (Eguchi-Ogawa et al., 2007), we are unaware which CD1 molecule is detected by the antibody used.
Whilst CD83 is a known marker of DC maturation in both humans (Zhou and Tedder, 1996) and mice (Berchtold et al., 1999), recent studies highlight species differences regarding MoDC CD83 expression (Moyo et al., 2013). Although the expression was significantly up-regulated with maturation cocktail, CD83 expression in iMoDCs suggests that pigs are more similar to horses and unlike humans or mice which do not express CD83 on iMoDCs. CD206 expression is reportedly hallmark of human iDCs, absent on monocytes and mDC (Sallusto and Lanzavecchia, 1994; Mellman et al., 1998; Cochand et al., 1999), however, it would appear that poMoDCs are again different and rather similar to horses, where its modulation on MoDC is variable (Mauel et al., 2006).
CD14, a marker of monocytes and macrophages, not expressed by human blood-DCs (Thomas et al., 1993), was expressed by poMoDCs and decreased following maturation. CD14 is also expressed in MoDCs in other species including cat, cattle, and dog (Miranda de Carvalho et al., 2006). Some poMoDC studies (Paillot et al., 2001; Chamorro et al., 2004) suggest the absence of CD14 following maturation, although Carrasco et al. (2001) report increased CD14 following MoDC maturation (Carrasco et al., 2001). Such discrepancy could be owing to differences in the differentiation protocol. Carrasco et al. (2001) used autologous porcine serum for differentiation, often used for differentiation of macrophages, and these cells may have maintained some MoMØ characteristics.
Porcine MoDC Respond to IL-10 and Dexamethasone by Modulation of Phenotype and Function
Whilst little was known about the effects of dexa on poMoDC prior to this study, reports suggested that glucocorticoids impair human MoDC differentiation and maturation (Woltman et al., 2000; Bengtsson et al., 2004), and that IL-10 induces a regulatory subset of DCs (Velten et al., 2004).
Dexa induced significant changes to MoDC phenotype, resulting in a phenotype unlike iMoDC nor mMoDC. MHC-II expression remained high, while the phenotype was otherwise inconsistent with maturation, also found to occur in human MoDCs treated with dexa (Duperrier et al., 2005). Differences between CD80/86 and CD83 positive cells in mMoDC and dexa MoDC support the theory that dexa inhibits maturation, as does our finding that dexa MoDCs express significantly increased CD14, exceeding that of porcine MoMØ. This finding aligns with other studies (Piemonti et al., 1999; Canning et al., 2000; Duperrier et al., 2005), and strengthens suggestion of an altered status. Importantly, CD163 and CD169 expression by poMoDC remained negligible following DC treatment with either dexa or IL-10. Unlike dexa, IL-10 failed to significantly modulate the MoDC phenotype, in line with IL-10 inhibition of human DC maturation (Buelens et al., 1997).
Despite variable endocytosis and phagocytosis, due to variability amongst animals, a significant difference was observed between the endocytic activity of dexa MoDC and iMoDC, and IL-10 increased phagocytic activity of poMoDCs, consistent with the increased antigen capture ability described in human IL-10-treated MoDCs, which maintain iMoDC characteristics (Morel et al., 1997). Increased endocytic activity was also described in humans (Longoni et al., 1998) and although not significant, our data confirm a trend to this effect.
Infection of Porcine MoDC Subsets with PRRSV-1
Porcine reproductive and respiratory virus 1 replication in iMoDC remained low throughout the observation period of 72 h in both cells and cell supernatant. Another PRRSV-1 MoDC infection study also highlights variation between virus strains (Silva-Campa et al., 2010), suggesting that a strain specific feature of Lena might be to replicate poorly in MoDC. Interestingly, the same study suggests that DCs remain in an immature state following infection, as shown for PRRSV-2 strains (Wang et al., 2007; Flores-Mendoza et al., 2008), denoting that PRRSV favors replication in iMoDCs, consistent with data obtained here. It should be considered, however, that the maturation cocktail used contained IFN-γ, the anti-viral effects of which were discussed above.
Virus was not detected in supernatant until 24 h p.i., which mirrored the time-point where infection peaked in cells and indicated a significantly slower replication rate than in MoMØs. Interestingly, both dexa and IL-10 MoDCs reached peak virus replication even later. Absence of CD163 and CD169 on MoDCs, and the ability to infect such cells in principle, indicates that PRRSV infection of DCs may involve receptors not yet identified. It could be considered that DCs might become infected through uptake of bystander infected apoptotic cells. This, proposed by others (Frydas et al., 2013), would require further investigation using mixed cell cultures to demonstrate MoDCs infection as a consequence of other susceptible cells present. Whilst slow viral growth of PRRSV-2 has been associated with older pigs with increased viral resistance (Klinge et al., 2009), it is unlikely to explain the low infection levels observed in MoDCs here, since monocytes from the same animals showed high infection in parallel experiments.
In summary, PRRSV-1 is able to replicate in porcine myeloid cells in various states of activation or maturation, however, replication is much slower in MoDCs than in MoMØs. Dexa and IL-10 were both shown to promote PRRSV replication in macrophages, but failed to influence MoDCs in the same manner. Both IL-10 and dexa are known to act on MoDCs, but their inability to modulate CD163 and CD169 on these cells specifically makes up-regulation of these the most likely action by which PRRSV-1 replication is increased. Further investigation using a higher m.o.i. and measuring viral proteins in combination with CD163 and CD169 would be required to determine co-localization. Reports describing IL-10 production by PRRSV as a mechanism of immune suppression have been discussed controversially (Suradhat et al., 2003; Díaz et al., 2006). Our findings suggest an additional role of IL-10 in promoting PRRSV-1 replication. Given that DCs are considered the most professional APCs, the slow and inefficient infection of MoDCs may also explain the delay in T-lymphocyte response to PRRSV, possibly providing PRRSV with an elegant immune evasion mechanism.
FS, JP-F, and SG designed the study and all authors contributed to the acquisition, analysis and/or interpretation of data for further work. HS drafted the manuscript, which was further evaluated by all authors for its content and form. All authors have seen and finally approved the version submitted for publication.
Animal and Plant Health Agency seedcorn studentship; Grant 245141 of the Seventh Framework Programme of the European Union: PoRRSCon – PRRS: new generation, efficacious and safe vaccine, new control strategies; Defra project SE0529; COST Action FA902: Understanding and combating porcine reproductive and respiratory syndrome in Europe.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/article/10.3389/fmicb.2016.00832
FIGURE S1 | Morphology of MoMØs. Four-day-old MoMØs were either left unstimulated, (A), or treated for 24 h with either IFN-γ and LPS to obtain M1-like MoMØs (B) or with IL-4 to obtain M2-like MoMØs (C). Alternatively, four-day-old MoMØs were treated with either IL-10 (D), or with dexa (E). Light microscopy photographs were taken after 24 h with cytokines and are representative of three independent experiments. Magnification is 20×.
FIGURE S2 | Data summarizing flow cytometric analysis of M1 and M2 MoMØ endocytosis. The ability of unstimulated MoMØs or MoMØs treated with M1 or M2 cytokines to endocytose was assessed using APC*-labeled OVA. Cells were incubated with OVA at 4°C as a negative control (blue dots), or at 37°C (red dots), for 1 h before flow cytometric analysis of APC* fluorescence. Dots represent individual experiments, showing the percentage of cells fluorescing APC*, indicating endocytic OVA uptake. Lines represent mean percentage of cells associated with OVA-APC* ±SEM.
FIGURE S3 | Data summarizing flow cytometric analysis of M1 and M2 MoMØ phagocytosis. The ability of unstimulated MoMØs or MoMØs treated with M1 or M2 cytokines to phagocytose was assessed using FITC-labeled microsphere particles. Cells were incubated with particles at 4°C as a negative control (blue dots), or at 37°C (red dots), for 3 h before flow cytometric analysis of FITC fluorescence. Dots represent individual experiments, showing the percentage of cells fluorescing FITC, indicating phagocytic uptake. Lines represent mean percentage of cells associated with FITC microsphere particles ±SEM.
FIGURE S4 | Endocytic Activity of MoMØs following dexa and IL-10 treatment. The ability of unstimulated MoMØs or MoMØs treated with dexa or IL-10 to endocytose was assessed using APC*-labeled OVA. Cells were incubated with OVA for 1 h at 4°C (blue) or 37°C (red) before flow cytometric analysis of percentages of cells associated with APC*-OVA. Dots represent individual experiments; lines represent mean percentages ±SEM. One-way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison test, *p < 0.05.
FIGURE S5 | Phagocytic Activity of Dexa and IL-10 MoMØs. The ability of unstimulated MoMØs or MoMØs treated with dexa or IL-10 to phagocytose FITC-labeled microsphere particles was measured after 24 h of treatment with these factors. Cells were incubated with microsphere particles for 3 h, both at 4°C (blue) or 37°C (red) before flow cytometric analysis. Dots represent individual experiments, lines represent mean percentages ±SEM. One-way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison test, *p < 0.05.
FIGURE S6 | Intracellular PRRSV staining using SDOW-17 in MoMØ subsets. Monocytes were treated with M-CSF for 4 days to generate MoMØs, and either left unstimulated or activated with LPS and IFN-γ (M1), IL-4 (M2), dexa, or IL-10 for 24 h before infection with PRRSV Lena. At 20 h p.i cells were harvested and stained with a LIVE/DEAD Violet stain before being permeabilized and fixed for intracellular staining with α-PRRSV antibody SDOW-17 and secondary G1-APC* for detection by flow cytometry. Cells were gated on FSC/SSC (A) before dead cells were eliminated according to LIVE/DEAD Violet stain (B). For negative controls, cells were stained with secondary G1-APC* only (C) and with a mouse IgG1 isotype and secondary G1-APC* (D). SDOW-APC* staining is shown in mock infected MoMØs (E) and in unstimulated (F), M1 (G), M2 (H), dexa (I), IL-10 (J) treated MoMØs. Data are representative of three independent experiments.
FIGURE S7 | Morphology of MoDCs. Four-day-old MoDCs were either left untreated, (A), or treated for 24 h with a maturation cocktail containing LPS, IFN-γ, IL-6, TNF-α, IL-1β, and PGE2 (B). Alternatively, four-day-old MoDCs were treated for 24 h with IL-10 (C) or dexa (D). Light microscopy photographs are representative of three independent experiments. Magnification is 20×.
DC, dendritic cell; dexa, dexamethasone; GM-CSF, granulocyte macrophage-colony stimulating factor; iDC, immature dendritic cell; LPS, lipopolysaccharide; M-CSF, macrophage-colony stimulating factor; mDC, mature dendritic cell; MØ, macrophage; MoDC, monocyte-derived dendritic cell; MoMØ, monocyte-derived macrophage; M1, MoMØ treated with IFN-γ/LPS; M2, MoMØ treated with IL-4; PBMC, peripheral blood mononuclear cell; pDC, plasmacytoid dendritic cell; PGE2, prostaglandin E2; PoMoDC, porcine monocyte-derived dendritic cell; PoMoMØ, porcine monocyte-derived macrophage; PRRSV, porcine reproductive and respiratory syndrome.
Ait-Ali, T., Wilson, A., Westcott, D., Clapperton, M., Waterfall, M., Mellenchamp, M., et al. (2007). Innate immune responses to replication of porcine reproductive and respiratory syndrome virus in isolated swine alveolar macrophages. Gene 20, 105–118.
Becker, J., and Grasso, R. J. (1985). Suppression of phagocytosis by dexamethasone in macrophage cultures: inability of arachidonic acid, indomethacin, and nordihydroguaiaretic acid to reverse the inhibitory response mediated by a steroid-inducible factor. Int. J. Immunopharmacol. 7, 839–847. doi: 10.1016/0192-0561(85)90046-3
Bengtsson, A. K., Ryan, E. J., Giordano, D., Magaletti, D. M., and Clark, E. A. (2004). 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 104, 1404–1410. doi: 10.1182/blood-2003-10-3380
Berchtold, S., Muhl-Zurbes, P., Heufler, C., Winklehner, P., Schuler, G., and Steinkasserer, A. (1999). Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation. FEBS Lett. 461, 211–216. doi: 10.1016/S0014-5793(99)01465-9
Bollen, M., Gijsbers, R., Ceulemans, H., Stalmans, W., and Stefan, C.(2000). Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit. Rev. Biochem. Mol. Biol. 35, 393–432. doi: 10.1080/10409230091169249
Buelens, C., Verhasselt, V., De Groote, D., Thielemans, K., Goldman, M., and Willems, F. (1997). Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol. 27, 1848–1852. doi: 10.1002/eji.1830270805
Calvert, J. G., Slade, D. E., Shields, S. L., Jolie, R., Mannan, R. M., Ankenbauer, R. G., et al. (2007). CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses. J. Virol. 81, 7371–7379. doi: 10.1128/JVI.00513-07
Canning, M. O., Grotenhuis, K., de Wit, H. J., and Drexhage, H. A. (2000). Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur. J. Endocrinol. 143, 687–695. doi: 10.1530/eje.0.1430687
Cao, X., Sugita, M., Van Der Wel, N., Lai, J., Rogers, R. A., Peters, P. J., et al. (2002). CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J. Immunol. 169, 4770–4777. doi: 10.4049/jimmunol.169.9.4770
Carrasco, C. P., Rigden, R. C., Schaffner, R., Gerber, H., Neuhaus, V., Inumaru, S., et al. (2001). Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104, 175–184. doi: 10.1046/j.1365-2567.2001.01299.x
Chamorro, S., Revilla, C., Gomez, N., Alvarez, B., Alonso, F., Ezquerra, A., et al. (2004). In vitro differentiation of porcine blood CD163- and CD163+ monocytes into functional dendritic cells. Immunobiology 209, 57–65. doi: 10.1016/j.imbio.2004.02.002
Chang, H. C., Peng, Y. T., Chang, H. L., Chaung, H. C., and Chung, W. B. (2008). Phenotypic and functional modulation of bone marrow-derived dendritic cells by porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 129, 281–293. doi: 10.1016/j.vetmic.2007.12.002
Cochand, L., Isler, P., Songeon, F., and Nicod, L. P. (1999). Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am. J. Respir. Cell Mol. Biol. 21, 547–554. doi: 10.1165/ajrcmb.21.5.3785
Das, P. B., Dinh, P. X., Ansari, I. H., de Lima, M., Osorio, F. A., and Pattnaik, A. K. (2010). The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J. Virol. 84, 1731–1740. doi: 10.1128/JVI.01774-09
Diaz, I., Darwich, L., Pappaterra, G., Pujols, J., and Mateu, E. (2005). Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 86, 1943–1951. doi: 10.1099/vir.0.80959-0
Díaz, I., Darwich, L., Pappaterra, G., Pujols, J., and Mateu, E. (2006). Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology 351, 249–259. doi: 10.1016/j.virol.2006.03.046
Duan, X., Nauwynck, H. J., and Pensaert, M. B. (1997a). Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV). Arch. Virol. 142, 2483–2497. doi: 10.1007/s007050050256
Duan, X., Nauwynck, H. J., and Pensaert, M. B. (1997b). Virus quantification and identification of cellular targets in the lungs and lymphoid tissues of pigs at different time intervals after inoculation with porcine reproductive and respiratory syndrome virus (PRRSV). Vet. Microbiol. 56, 9–19. doi: 10.1016/S0378-1135(96)01347-8
Duperrier, K., Velten, F. W., Bohlender, J., Demory, A., Metharom, P., and Goerdt, S. (2005). Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. Mol. Immunol. 42, 1531–1540. doi: 10.1016/j.molimm.2005.01.006
Eguchi-Ogawa, T., Morozumi, T., Tanaka, M., Shinkai, H., Okumura, N., Suzuki, K., et al. (2007). Analysis of the genomic structure of the porcine CD1 gene cluster. Genomics 89, 248–261. doi: 10.1016/j.ygeno.2006.10.003
Ezquerra, A., Revilla, C., Alvarez, B., Perez, C., Alonso, F., and Dominguez, J. (2009). Porcine myelomonocytic markers and cell populations. Dev. Comp. Immunol. 33, 284–298. doi: 10.1016/j.dci.2008.06.002
Facci, M. R., Auray, G., Buchanan, R., van Kessel, J., Thompson, D. R., Mackenzie-Dyck, S., et al. (2010). A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs. Immunology 129, 396–405. doi: 10.1111/j.1365-2567.2009.03192.x
Flores-Mendoza, L., Silva-Campa, E., Resendiz, M., Osorio, F. A., and Hernandez, J. (2008). Porcine reproductive and respiratory syndrome virus infects mature porcine dendritic cells and up-regulates interleukin-10 production. Clin. Vaccine Immunol. 15, 720–725. doi: 10.1128/CVI.00224-07
Forsberg, R., Storgaard, T., Nielsen, H. S., Oleksiewicz, M. B., Cordioli, P., Sala, G., et al. (2002). The genetic diversity of european type PRRSV is similar to that of the North American type but is geographically skewed within Europe. Virology 299, 38–47. doi: 10.1006/viro.2002.1450
Frossard, J. P., Fearnley, C., Naidu, B., Errington, J., Westcott, D. G., and Drew, T. W. (2012). Porcine reproductive and respiratory syndrome virus: antigenic and molecular diversity of British isolates and implications for diagnosis. Vet. Microbiol. 158, 308–315. doi: 10.1016/j.vetmic.2012.03.004
Frydas, I. S., Verbeeck, M., Cao, J., and Nauwynck, H. J. (2013). Replication characteristics of porcine reproductive and respiratory syndrome virus (PRRSV) European subtype 1 (Lelystad) and subtype 3 (Lena) strains in nasal mucosa and cells of the monocytic lineage: indications for the use of new receptors of PRRSV (Lena). Vet. Res. 44, 73. doi: 10.1186/1297-9716-44-73
Geijtenbeek, T. B., Krooshoop, D. J., Bleijs, D. A., van Vliet, S. J., van Duijnhoven, G. C., Grabovsky, V., et al. (2000). DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 1, 353–357. doi: 10.1038/79815
Genovesi, E. V., Villinger, F., Gerstner, D. J., Whyard, T. C., and Knudsen, R. C. (1990). Effect of macrophage-specific colony-stimulating factor (CSF-1) on swine monocyte/macrophage susceptibility to in vitro infection by African swine fever virus. Vet. Microbiol. 25, 153–176. doi: 10.1016/0378-1135(90)90074-6
Goding, J. W., Grobben, B., and Slegers, H. (2003). Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim. Biophys. Acta 1638, 1–19. doi: 10.1016/S0925-4439(03)00058-9
Gomez-Laguna, J., Salguero, F. J., Pallares, F. J., and Carrasco, L. (2013). Immunopathogenesis of porcine reproductive and respiratory syndrome in the respiratory tract of pigs. Vet. J. 195, 148–155. doi: 10.1016/j.tvjl.2012.11.012
Gratchev, A., Guillot, P., Hakiy, N., Politz, O., Orfanos, C. E., Schledzewski, K., et al. (2001). Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand. J. Immunol. 53, 386–392. doi: 10.1046/j.1365-3083.2001.00885.x
Haynes, J. S., Halbur, P. G., Sirinarumitr, T., Paul, P. S., Meng, X. J., and Huffman, E. L. (1997). Temporal and morphologic characterization of the distribution of porcine reproductive and respiratory syndrome virus (PRRSV) by in situ hybridization in pigs infected with isolates of PRRSV that differ in virulence. Vet. Pathol. 34, 39–43. doi: 10.1177/030098589703400106
Held, T. K., Weihua, X., Yuan, L., Kalvakolanu, D. V., and Cross, A. S. (1999). Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect. Immun. 67, 206–212.
Hogger, P., Dreier, J., Droste, A., Buck, F., and Sorg, C. (1998). Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J. Immunol. 161, 1883–1890.
Hopper, S. A., White, M. E., and Twiddy, N. (1992). An outbreak of blue-eared pig disease (porcine reproductive and respiratory syndrome) in four pig herds in Great Britain. Vet. Rec. 131, 140–144. doi: 10.1136/vr.131.7.140
Howard, C. J., Brooke, G. P., Werling, D., Sopp, P., Hope, J. C., Parsons, K. R., et al. (1999). Dendritic cells in cattle: phenotype and function. Vet. Immunol. Immunopathol. 72, 119–124. doi: 10.1016/S0165-2427(99)00124-5
Jeras, M., Bergant, M., and Repnik, U. (2005). In vitro preparation and functional assessment of human monocyte-derived dendritic cells-potential antigen-specific modulators of in vivo immune responses. Transpl. Immunol. 14, 231–244. doi: 10.1016/j.trim.2005.03.012
Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M., et al. (1995). The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151–155. doi: 10.1038/375151a0
Kapetanovic, R., Fairbairn, L., Beraldi, D., Sester, D. P., Archibald, A. L., Tuggle, C. K., et al. (2012). Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J. Immunol. 188, 3382–3394. doi: 10.4049/jimmunol.1102649
Karniychuk, U. U., Geldhof, M., Vanhee, M., Van Doorsselaere, J., Saveleva, T. A., and Nauwynck, H. J. (2010). Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate. BMC Vet. Res. 6:30. doi: 10.1186/1746-6148-6-30
Karniychuk, U. U., and Nauwynck, H. J. (2009). Quantitative changes of sialoadhesin and CD163 positive macrophages in the implantation sites and organs of porcine embryos/fetuses during gestation. Placenta 30, 497–500. doi: 10.1016/j.placenta.2009.03.016
Klinge, K. L., Vaughn, E. M., Roof, M. B., Bautista, E. M., and Murtaugh, M. P. (2009). Age-dependent resistance to Porcine reproductive and respiratory syndrome virus replication in swine. Virol. J. 6, 177. doi: 10.1186/1743-422X-6-177
Larochelle, R., Mardassi, H., Dea, S., and Magar, R. (1996). Detection of porcine reproductive and respiratory syndrome virus in cell cultures and formalin-fixed tissues by in situ hybridization using a digoxigenin-labeled probe. J. Vet. Diagn. Invest. 8, 3–10. doi: 10.1177/104063879600800102
Lawson, S. R., Rossow, K. D., Collins, J. E., Benfield, D. A., and Rowland, R. R. (1997). Porcine reproductive and respiratory syndrome virus infection of gnotobiotic pigs: sites of virus replication and co-localization with MAC-387 staining at 21 days post-infection. Virus Res. 51, 105–113. doi: 10.1016/S0168-1702(97)00086-5
Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408. doi: 10.1006/meth.2001.1262
Longoni, D., Piemonti, L., Bernasconi, S., Mantovani, A., and Allavena, P. (1998). Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells. Int. J. Clin. Lab. Res. 28, 162–169. doi: 10.1007/s005990050037
Loving, C. L., Brockmeier, S. L., and Sacco, R. E. (2007). Differential type I interferon activation and susceptibility of dendritic cell populations to porcine arterivirus. Immunology 120, 217–229. doi: 10.1111/j.1365-2567.2006.02493.x
Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677–686. doi: 10.1016/j.it.2004.09.015
Martinez, F. O., Gordon, S., Locati, M., and Mantovani, A. (2006). Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303–7311. doi: 10.4049/jimmunol.177.10.7303
Mauel, S., Steinbach, F., and Ludwig, H. (2006). Monocyte-derived dendritic cells from horses differ from dendritic cells of humans and mice. Immunology 117, 463–473. doi: 10.1111/j.1365-2567.2005.02319.x
Mayer, P. (1983). The growth of swine bone marrow cells in the presence of heterologous colony stimulating factor: characterization of the developing cell population. Comp. Immunol. Microbiol. Infect. Dis. 6, 171–187. doi: 10.1016/0147-9571(83)90008-5
McCullough, K. C., Basta, S., Knotig, S., Gerber, H., Schaffner, R., Kim, Y. B., et al. (1999). Intermediate stages in monocyte-macrophage differentiation modulate phenotype and susceptibility to virus infection. Immunology 98, 203–212. doi: 10.1046/j.1365-2567.1999.00867.x
McCullough, K. C., Schaffner, R., Fraefel, W., and Kihm, U. (1993). The relative density of CD44-positive porcine monocytic cell populations varies between isolations and upon culture and influences susceptibility to infection by African swine fever virus. Immunol. Lett. 37, 83–90. doi: 10.1016/0165-2478(93)90136-P
McCullough, K. C., Schaffner, R., Natale, V., Kim, Y. B., and Summerfield, A. (1997). Phenotype of porcine monocytic cells: modulation of surface molecule expression upon monocyte differentiation into macrophages. Vet. Immunol. Immunopathol. 58, 265–275. doi: 10.1016/S0165-2427(97)00045-7
Miranda de Carvalho, C., Bonnefont-Rebeix, C., Rigal, D., and Chabanne, L. (2006). Dendritic cells in different animal species: an overview. Pathol. Biol. (Paris) 54, 85–93. doi: 10.1016/j.patbio.2005.04.005
Mizukoshi, F., Baba, K., Horiuchi, H., Goto-Koshino, Y., Setoguchi-Mukai, A., Fujino, Y., et al. (2009). Characterization of monocyte-derived dendritic cells from cats infected with feline immunodeficiency virus. J. Vet. Med. Sci. 71, 865–871. doi: 10.1292/jvms.71.865
Modolell, M., Corraliza, I. M., Link, F., Soler, G., and Eichmann, K. (1995). Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25, 1101–1104. doi: 10.1002/eji.1830250436
Montoya, D., Cruz, D., Teles, R. M., Lee, D. J., Ochoa, M. T., Krutzik, S. R., et al. (2009). Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6, 343–353. doi: 10.1016/j.chom.2009.09.002
Morel, A. S., Quaratino, S., Douek, D. C., and Londei, M. (1997). Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur. J. Immunol. 27, 26–34. doi: 10.1002/eji.1830270105
Morgan, S. B., Graham, S. P., Salguero, F. J., Sanchez Cordon, P. J., Mokhtar, H., Rebel, J. M., et al. (2013). Increased pathogenicity of European porcine reproductive and respiratory syndrome virus is associated with enhanced adaptive responses and viral clearance. Vet. Microbiol. 163, 13–22. doi: 10.1016/j.vetmic.2012.11.024
Moyo, N. A., Marchi, E., and Steinbach, F. (2013). Differentiation and activation of equine monocyte-derived dendritic cells is not correlated with CD206 or CD83 expression. Immunology. 139, 472–483. doi: 10.1111/imm.12094
Paillot, R., Laval, F., Audonnet, J. C., Andreoni, C., and Juillard, V. (2001). Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes. Immunology 102, 396–404. doi: 10.1046/j.1365-2567.2001.01200.x
Park, J. Y., Kim, H. S., and Seo, S. H. (2008). Characterization of interaction between porcine reproductive and respiratory syndrome virus and porcine dendritic cells. J. Microbiol. Biotechnol. 18, 1709–1716.
Piemonti, L., Monti, P., Allavena, P., Leone, B. E., Caputo, A., and Di Carlo, V. (1999). Glucocorticoids increase the endocytic activity of human dendritic cells. Int. Immunol. 11, 1519–1526. doi: 10.1093/intimm/11.9.1519
Pilon, C., Levast, B., Meurens, F., Le Vern, Y., Kerboeuf, D., Salmon, H., et al. (2009). CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1. Mol. Immunol. 46, 437–447. doi: 10.1016/j.molimm.2008.10.014
Porcheray, F., Viaud, S., Rimaniol, A. C., Leone, C., Samah, B., Dereuddre-Bosquet, N., et al. (2005). Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481–489. doi: 10.1111/j.1365-2249.2005.02934.x
Prather, R. S., Rowland, R. R., Ewen, C., Trible, B., Kerrigan, M., Bawa, B., et al. (2013). An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus. J. Virol. 87, 9538–9546. doi: 10.1128/JVI.00177-13
Relloso, M., Puig-Kroger, A., Pello, O. M., Rodriguez-Fernandez, J. L., de la Rosa, G., Longo, N., et al. (2002). DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J. Immunol. 168, 2634–2643. doi: 10.4049/jimmunol.168.6.2634
Rey-Giraud, F., Hafner, M., and Ries, C. H. (2012). In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS ONE 7:e42656. doi: 10.1371/journal.pone.0042656
Rowland, R. R., Robinson, B., Stefanick, J., Kim, T. S., Guanghua, L., Lawson, S. R., et al. (2001). Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine. Arch. Virol. 146, 539–555. doi: 10.1007/s007050170161
Salguero, F. J., Frossard, J. P., Rebel, J. M., Stadejek, T., Morgan, S. B., Graham, S. P., et al. (2015). Host-pathogen interactions during porcine reproductive and respiratory syndrome virus 1 infection of piglets. Virus Res. 202, 135–143. doi: 10.1016/j.virusres.2014.12.026
Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389–400. doi: 10.1084/jem.182.2.389
Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109–1118. doi: 10.1084/jem.179.4.1109
Scandella, E., Men, Y., Gillessen, S., Forster, R., and Groettrup, M. (2002). Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100, 1354–1361. doi: 10.1182/blood-2001-11-0017
Scheibenbogen, C., Keilholz, U., Richter, M., Andreesen, R., and Hunstein, W. (1992). The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75). Res. Immunol. 143, 33–37. doi: 10.1016/0923-2494(92)80077-X
Schook, L., Beattie, C., Beever, J., Donovan, S., Jamison, R., Zuckermann, F., et al. (2005). Swine in biomedical research: creating the building blocks of animal models. Anim. Biotechnol. 16, 183–190. doi: 10.1080/10495390500265034
Silva-Campa, E., Cordoba, L., Fraile, L., Flores-Mendoza, L., Montoya, M., and Hernández, J. (2010). European genotype of porcine reproductive and respiratory syndrome (PRRSV) infects monocyte-derived dendritic cells but does not induce Treg cells. Virology 396, 264–271. doi: 10.1016/j.virol.2009.10.024
Stadejek, T., Oleksiewicz, M. B., Scherbakov, A. V., Timina, A. M., Krabbe, J. S., Chabros, K., et al. (2008). Definition of subtypes in the European genotype of porcine reproductive and respiratory syndrome virus: nucleocapsid characteristics and geographical distribution in Europe. Arch. Virol. 153, 1479–1488. doi: 10.1007/s00705-008-0146-2
Stadejek, T., Stankevicius, A., Murtaugh, M. P., and Oleksiewicz, M. B. (2013). Molecular evolution of PRRSV in Europe: current state of play. Vet. Microbiol. 165, 21–28. doi: 10.1016/j.vetmic.2013.02.029
Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287–292. doi: 10.1084/jem.176.1.287
Sur, J. H., Cooper, V. L., Galeota, J. A., Hesse, R. A., Doster, A. R., and Osorio, F. A. (1996). In vivo detection of porcine reproductive and respiratory syndrome virus RNA by in situ hybridization at different times postinfection. J. Clin. Microbiol. 34, 2280–2286.
Suradhat, S., Thanawongnuwech, R., and Poovorawan, Y. (2003). Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 84, 453–459. doi: 10.1099/vir.0.19230-0
Teifke, J. P., Dauber, M., Fichtner, D., Lenk, M., Polster, U., Weiland, E., et al. (2001). Detection of European porcine reproductive and respiratory syndrome virus in porcine alveolar macrophages by two-colour immunofluorescence and in-situ hybridization-immunohistochemistry double labelling. J. Comp. Pathol. 124, 238–245. doi: 10.1053/jcpa.2000.0458
Thacker, E. L., Halbur, P. G., Paul, P. S., and Thacker, B. J. (1998). Detection of intracellular porcine reproductive and respiratory syndrome virus nucleocapsid protein in porcine macrophages by flow cytometry. J. Vet. Diagn. Invest. 10, 308–311. doi: 10.1177/104063879801000319
Thoma-Uszynski, S., Stenger, S., Takeuchi, O., Ochoa, M. T., Engele, M., Sieling, P. A., et al. (2001). Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291, 1544–1547. doi: 10.1126/science.291.5508.1544
Tong, G. Z., Zhou, Y. J., Hao, X. F., Tian, Z. J., An, T. Q., and Qiu, H. J. (2007). Highly pathogenic porcine reproductive and respiratory syndrome, China. Emerg. Infect. Dis. 13, 1434–1436. doi: 10.3201/eid1309.070399
Van Breedam, W., Delputte, P. L., Van Gorp, H., Misinzo, G., Vanderheijden, N., Duan, X., et al. (2010a). Porcine reproductive and respiratory syndrome virus entry into the porcine macrophage. J. Gen. Virol. 91, 1659–1667. doi: 10.1099/vir.0.020503-0
Van Breedam, W., Van Gorp, H., Zhang, J. Q., Crocker, P. R., Delputte, P. L., and Nauwynck, H. J. (2010b). The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner. PLoS Pathog. 6:e1000730. doi: 10.1371/journal.ppat.1000730
Van Gorp, H., Van Breedam, W., Delputte, P. L., and Nauwynck, H. J. (2008). Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 89, 2943–2953. doi: 10.1099/vir.0.2008/005009-0
Vanderheijden, N., Delputte, P. L., Favoreel, H. W., Vandekerckhove, J., Van Damme, J., van Woensel, P. A., et al. (2003). Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J. Virol. 77, 8207–8215. doi: 10.1128/JVI.77.15.8207-8215.2003
Velten, F. W., Duperrier, K., Bohlender, J., Metharom, P., and Goerdt, S. (2004). A gene signature of inhibitory MHC receptors identifies a BDCA3(+) subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro. Eur. J. Immunol. 34, 2800–2811. doi: 10.1002/eji.200324732
Vereyken, E. J., Heijnen, P. D., Baron, W., de Vries, E. H., Dijkstra, C. D., and Teunissen, C. E. (2011). Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J. Neuroinflammation 8, 58. doi: 10.1186/1742-2094-8-58
Verreck, F. A., de Boer, T., Langenberg, D. M., Hoeve, M. A., Kramer, M., Vaisberg, E., et al. (2004). Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. U.S.A. 101, 4560–4565. doi: 10.1073/pnas.0400983101
Vincent, A. L., Thacker, B. J., Halbur, P. G., Rothschild, M. F., and Thacker, E. L. (2005). In vitro susceptibility of macrophages to porcine reproductive and respiratory syndrome virus varies between genetically diverse lines of pigs. Viral Immunol. 18, 506–512. doi: 10.1089/vim.2005.18.506
Wang, X., Eaton, M., Mayer, M., Li, H., He, D., Nelson, E., et al. (2007). Porcine reproductive and respiratory syndrome virus productively infects monocyte-derived dendritic cells and compromises their antigen-presenting ability. Arch. Virol. 152, 289–303. doi: 10.1007/s00705-006-0857-1
Weesendorp, E., Morgan, S., Stockhofe-Zurwieden, N., Popma-De Graaf, D. J., Graham, S. P., and Rebel, J. M. (2013). Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence. Vet. Microbiol. 163, 1–12. doi: 10.1016/j.vetmic.2012.09.013
Whyte, C. S., Bishop, E. T., Ruckerl, D., Gaspar-Pereira, S., Barker, R. N., Allen, J. E., et al. (2011). Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J. Leukoc. Biol. 90, 845–854. doi: 10.1189/jlb.1110644
Woltman, A. M., de Fijter, J. W., Kamerling, S. W., Paul, L. C., Daha, M. R., and van Kooten, C. (2000). The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30, 1807–1812. doi: 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N
Zahuczky, G., Kristof, E., Majai, G., and Fesus, L. (2011). Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages. Role of Mertk in enhanced phagocytosis. PLoS ONE 6:e21349. doi: 10.1371/journal.pone.0021349
Keywords: PRRSV, macrophage, dendritic cell, CD163, CD169
Citation: Singleton H, Graham SP, Bodman-Smith KB, Frossard J-P and Steinbach F (2016) Establishing Porcine Monocyte-Derived Macrophage and Dendritic Cell Systems for Studying the Interaction with PRRSV-1. Front. Microbiol. 7:832. doi: 10.3389/fmicb.2016.00832
Received: 12 January 2016; Accepted: 17 May 2016;
Published: 02 June 2016.
Edited by:Hao Shen, University of Pennsylvania School of Medicine, USA
Reviewed by:Michael P. Murtaugh, University of Minnesota, USA
Ryo Inoue, Kyoto Prefectural University, Japan
Copyright © 2016 Singleton, Graham, Bodman-Smith, Frossard and Steinbach. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Falko Steinbach, email@example.com